192 related articles for article (PubMed ID: 26628106)
1. Role of the endocannabinoid 2-arachidonoylglycerol in aversive responses mediated by the dorsolateral periaqueductal grey.
Gobira PH; Almeida-Santos AF; Guimaraes FS; Moreira FA; Aguiar DC
Eur Neuropsychopharmacol; 2016 Jan; 26(1):15-22. PubMed ID: 26628106
[TBL] [Abstract][Full Text] [Related]
2. Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats.
Viana TG; Hott SC; Resstel LB; Aguiar DC; Moreira FA
Psychopharmacology (Berl); 2015 May; 232(9):1545-53. PubMed ID: 25388290
[TBL] [Abstract][Full Text] [Related]
3. Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray.
Almeida-Santos AF; Gobira PH; Rosa LC; Guimaraes FS; Moreira FA; Aguiar DC
Behav Brain Res; 2013 Sep; 252():10-7. PubMed ID: 23714073
[TBL] [Abstract][Full Text] [Related]
4. Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses.
Batista LA; Bastos JR; Moreira FA
J Psychopharmacol; 2015 Mar; 29(3):335-43. PubMed ID: 25601395
[TBL] [Abstract][Full Text] [Related]
5. Activation of type 5 metabotropic glutamate receptors and diacylglycerol lipase-α initiates 2-arachidonoylglycerol formation and endocannabinoid-mediated analgesia.
Gregg LC; Jung KM; Spradley JM; Nyilas R; Suplita RL; Zimmer A; Watanabe M; Mackie K; Katona I; Piomelli D; Hohmann AG
J Neurosci; 2012 Jul; 32(28):9457-68. PubMed ID: 22787031
[TBL] [Abstract][Full Text] [Related]
6. Anti-aversive effect of 2-arachidonoylglycerol in the dorsolateral periaqueductal gray of male rats in contextual fear conditioning and Vogel tests.
Brianis RC; Lima RC; Moreira FA; Aguiar DC
Behav Pharmacol; 2022 Apr; 33(2&3):213-221. PubMed ID: 34074811
[TBL] [Abstract][Full Text] [Related]
7. Hypothalamic endocannabinoid signalling modulates aversive responses related to panic attacks.
Viana TG; Bastos JR; Costa RB; Hott SC; Mansur FS; Coimbra CC; Resstel LB; Aguiar DC; Moreira FA
Neuropharmacology; 2019 Apr; 148():284-290. PubMed ID: 30677422
[TBL] [Abstract][Full Text] [Related]
8. Differential role of CB1 and TRPV1 receptors on anandamide modulation of defensive responses induced by nitric oxide in the dorsolateral periaqueductal gray.
Lisboa SF; Guimarães FS
Neuropharmacology; 2012 Jun; 62(8):2455-62. PubMed ID: 22394688
[TBL] [Abstract][Full Text] [Related]
9. Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats.
Lisboa SF; Magesto AC; Aguiar JC; Resstel LB; Guimarães FS
Neuropharmacology; 2013 Dec; 75():86-94. PubMed ID: 23899460
[TBL] [Abstract][Full Text] [Related]
10. 2-Arachidonoylglycerol endocannabinoid signaling coupled to metabotropic glutamate receptor type-5 modulates anxiety-like behavior in the rat ventromedial prefrontal cortex.
Almeida-Santos AF; Moreira FA; Guimaraes FS; Aguiar DC
J Psychopharmacol; 2017 Jun; 31(6):740-749. PubMed ID: 28440729
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid CB
Batista LA; Moreira FA
Neurosci Lett; 2019 Jun; 703():5-10. PubMed ID: 30858018
[TBL] [Abstract][Full Text] [Related]
12. Possible inhibitory role of endogenous 2-arachidonoylglycerol as an endocannabinoid in (±)-epibatidine-induced activation of central adrenomedullary outflow in the rat.
Shimizu T; Tanaka K; Shimizu S; Higashi Y; Yawata T; Nakamura K; Taniuchi K; Ueba T; Yuri K; Saito M
Neuropharmacology; 2015 Aug; 95():278-89. PubMed ID: 25882827
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid modulation of predator fear: involvement of the dorsolateral periaqueductal gray.
Lisboa SF; Camargo LH; Magesto AC; Resstel LB; Guimarães FS
Int J Neuropsychopharmacol; 2014 Aug; 17(8):1193-206. PubMed ID: 24438603
[TBL] [Abstract][Full Text] [Related]
14. Activation of CB1 cannabinoid receptors in the dorsolateral periaqueductal gray reduces the expression of contextual fear conditioning in rats.
Resstel LB; Lisboa SF; Aguiar DC; Corrêa FM; Guimarães FS
Psychopharmacology (Berl); 2008 Jun; 198(3):405-11. PubMed ID: 18446325
[TBL] [Abstract][Full Text] [Related]
15. Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray.
Moreira FA; Aguiar DC; Guimarães FS
Neuropharmacology; 2007 Mar; 52(3):958-65. PubMed ID: 17156799
[TBL] [Abstract][Full Text] [Related]
16. Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain.
Guindon J; Guijarro A; Piomelli D; Hohmann AG
Br J Pharmacol; 2011 Aug; 163(7):1464-78. PubMed ID: 21198549
[TBL] [Abstract][Full Text] [Related]
17. Mu-opioid and CB1 cannabinoid receptors of the dorsal periaqueductal gray interplay in the regulation of fear response, but not antinociception.
Godoi MM; Junior HZ; da Cunha JM; Zanoveli JM
Pharmacol Biochem Behav; 2020 Jul; 194():172938. PubMed ID: 32376258
[TBL] [Abstract][Full Text] [Related]
18. Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition.
Ho YC; Lee HJ; Tung LW; Liao YY; Fu SY; Teng SF; Liao HT; Mackie K; Chiou LC
J Neurosci; 2011 Oct; 31(41):14600-10. PubMed ID: 21994376
[TBL] [Abstract][Full Text] [Related]
19. Role of TRPV1 receptors on panic-like behaviors mediated by the dorsolateral periaqueductal gray in rats.
Almeida-Santos AF; Moreira FA; Guimarães FS; Aguiar DC
Pharmacol Biochem Behav; 2013 Apr; 105():166-72. PubMed ID: 23474373
[TBL] [Abstract][Full Text] [Related]
20. The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nociceptive tone.
Olango WM; Roche M; Ford GK; Harhen B; Finn DP
Br J Pharmacol; 2012 Apr; 165(8):2549-60. PubMed ID: 21564082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
